Study Summary:
Open-label 52-week comparison of XXX vs. Olmesartan/HCTZ in subjects with moderate to severe systolic high blood pressure.
Qualified Participants Must:
Be 18 years or older with high blood pressure
Not have sulfa allergies
Be willing to attend up to 11 study visits in the mornings
Qualified Participants May Receive:
Study medication and study related procedures including blood pressure monitoring, laboratory tests, physical exams and EKG's at no cost. Compensation for time and travel will be provided to qualified participants.